Anti Malarial Drugs Blood schizonticides: Tissue schizonticides: – Chloroquine – Primaquine – Amodiaquine – Mefloquine – Quinine – Artemether Clinical Classification • Causal prophylaxis: – Chloroquine, primaquine, pyramathamine. • Clinical cure: – Chloroquine, amodaquine, mefloquine, quinine and artemether. • Radical cure: – Primaquine (p.vivax), pyramathamine (p.ovale) • Gamatocides: – Primaquine (p.vivax, p.falciperum) Chloroquine • Highly effective schizonticidal for all 4 types of plasmodium • Moderately effective against gametocytes (vivax, malarae, ovale but not falciperum) • It is not effective against pre- erythrocytic phase. MOA • Parasite depends upon the haeme as a source of energy. • Parasite polymerises haeme to form hemozoin. • Choloroquine inhibits the polymerases. As a result of that haeme can not be converted to haemozoin and accumulates inside the parasite. • Haeme is toxic for parasite. • Alkalinization of food vacuole: – The conversion of haeme to hemozoin is carried out in acidic media. – Chloroquine converts this acidic media to basic media so that it can not utilize haeme in alkaline media. • Decrease synthesis of DNA and RNA • Act by blocking the enzymatic synthesis of DNA and RNA. Resistance • Plasmodium falciperum develops resistance to chloroquine mostly. • Chloroquine resistant parasite expel chloroquine via p-glycoprotein pump similar to that described for multidrug resistance cancer cells. Clinical uses • Acute malarial attacks by, – P.M, P.F (non resistant), P.O, P.V (less effective) • Prophylaxis for all strains of malaria except for falciperum malaria which is resistant to chloroqiune. • Amebiasis ( amebic liver abcess) • Acute immune disorder Adverse effects • Low doses for prophylaxis (no S.E) • Slight high doses for treatment: – GIT disturbances; • Nausea vomiting diarrhea. – Pruritis, urticaria, skin rashes(black person) – Exacerbates dermatitis produced by gold – Anorexia, malaise, headache, psychosis are rare. – Blurring of vision (mostly develop early) – Damage the retina (high doses may produce irreversible damage) – ECG changes Contraindication Relative: Absolute: • Visual disturbances. • Cardiac disorder • Hepatic dysfunction. • Blood disorder • Severe G.I.T problem. • Dermatitis • Neuralgic disorder. • Psoriasis Drug interaction • Antacids: – E.g., magnesium trisilica, antidiarrheal e.g., kaolin interfere in absorption of chloroquine. • Chloroquine should be taken about 2 to 3 hours before or after antacid and antidiarrheal drug use. Mefloquine • Quinoline methanol derivative developed to deal with chloroquine resistant malaria • Rapidly acting erythrocytic schizonticide , slower than chloroquine & quinine • Effective against chloroquine sensitive & resistant plasmodia • Mechanism of action similar to chloroquine. Clinical uses • Multi drug resistant plasmodium falciperum. • Prophylaxis against P.O, P.V and plasmodium malarae. • The drug is highly effective against plasmodium falciperum but is reserved for chloroquine resistant areas • It can not be given in patients with cerebral malaria par-entrally. Side effects • At minor therapeutic dose: – GIT upset (Vomiting diarrhea gastritis) due to bitter taste. – Transient neuro-psychiatric problem (Dizziness, disorientation, hallucination) – Leukocytosis, thrombocytopenia. • At Higher dose: – Severe GIT upset – Severe neuro-psychiatric problem – Cardiac extra systole Contra-indication • Psychiatric disorder • Cardiac disorders: – Cardiac arrhythmias, cardiac conduction defect • First trimester of pregnancy Quinine • It is reserved for malaria strains resistant to other agents. • To treat palasmodium falciperum by I/V infusion in unconscious patient for 7 days. Mechanism of action • Interfere with heme polymerization • Results in cell death of plasmodium falciperum (erythrocytic phase) • Inhibits DNA synthesis Resistance • Resistance increased if used alone. • So used in combination with pyrimethamine, sulphadoxine, doxycycline, or clindamycin. Clinical uses • Blood schizomticidal for all four plasmodium • Gamatocidal for P.V and P.O not for P.F • No effect on sporozoits in liver Side effects • Gastric irritation (abdominal pain Nausea vomiting) • Cinchonism (tinnitus, Vertigo) • Visual disturbances • Hypersensitivity reaction • Cardiac depression • Curare like effects • Increase uterine contraction • Hypoglycemia (Inc insulin secretion) • Severe hypotention if used I/V Drug interaction • N.M blocking agents aggravates curare like actions • Digoxin, warfarin inc plasma half life. Primaquine • Weak action against erythrocytic stage of vivax • Eradicates exo-erythrocytic form of P.F and P.V. • Secondary exo-erythrocytic form of P.V and P.O (recurring malaria) Mechanism of action • Not well understood • They act as electron carrying redox compound which as reactive oxygen species and cause cell injury. Resistance • Some P.V are resistant to primaquine Clinical uses • Prophylaxis against P. ovale and P.V • Radical cure of P.V and P.O (schizont lying in liver) Side Effects • Epigastric pain • Nausea • Vomiting and abdominal cramps • Bone marrow supression • Leukopenia • Agranulocytosis • Hemolytic anemia in G6PD deficiency Contra-indication • First trimester of pregnancy • G6PD deficiency Pyrimethamine • MOA: – Inhibits plasmodial dihydrofolate reductase – Deprives tetrahydrofolate in plamodium which is a cofactor required for biosynthesis of purines and pyramidines and certain A.A Clinical uses • Tasteless so suitable for children • Blood schizonticidal and sporonticidal • Strong sporonticidal for mosquitos gut. When mosquito ingest blood of human host. • Used in combination with sulphadoxine (fansidar) • CHEMOPROPHYLAXIS: – Chloroquine resistant malaria. – Alternate to mefloquine while in endemic area of malaria for 4 weeks after leaving the area. • CLINICAL CURE: Side effects • Megaloblastic anemia • Thrombocytopenia • Agranulocytosis. Therapeutic options for treatment and prevention of • malaria Chloroquine resistant P.F: – Quinine + Pyrimethamine-sulfadoxine – Or Doxycycline – Or Clindamycin • Alternate: – Mefloquine • Prevention of relapse: – Chloroquine – In chloroquine resistant area: Mefloquine • In pregnancy: – Amidoquine or mefloquine
Microbes in the spotlight: recent progress in the understanding of beneficial and harmful microorganisms. ISBN-10:1627346120 ISBN-13: 978-1-627346-12-2. Editor: A. Méndez-Vilas Publisher: BrownWalker Press. Páginas 140-144. 2016.